
Some of the major players operating in the global rhytidectomy market are Millennium Surgical Corp, Lotus Surgicals, Antibe Therapeutics Inc., Baxter, and Make Me Heal. The global market for rhytidectomy is consolidated with a few large players dominating the scene. The global rhytidectomy market is technology and intellectual property intensive, which favors large players with deep pockets. The high cost of development is driving collaborations between players to reduce the development cost and time by benefiting from complementary technologies of each partner. However, the high premium of the market acts as a deterrent to collaborations as major players are hesitant to lose their market position and share.